Skip to main content
Fig. 6 | BMC Medical Ethics

Fig. 6

From: Pharmacy stakeholder reports on ethical and logistical considerations in anti-opioid vaccine development

Fig. 6

Pharmacist-reported perceptions regarding logistical barriers (a, b) and ethical concerns (c, d) for current treatments (a, c) and anti-opioid vaccines (b, d). All data plotted as mean ± SEM. Friedman with Dunn’s: *p < 0.05 vs. time; **p < 0.01 vs. time; ##p < 0.005 vs. time; ###p < 0.001 vs. time; ####p < 0.0001 vs. time; %p < 0.05 vs. provider availability; $$p < 0.01 vs. affordability of current OUD Treatments ^p < 0.05 vs. access inequality; ^^^p < 0.001 vs. access inequality; ^^^^p < 0.0001 vs. access inequality; +p < 0.05 vs. access inequality; +++p < 0.0005 vs. access inequality

Back to article page